Profil
David D.
House currently works at Armata Pharmaceuticals, Inc., as Chief Financial Officer & Senior VP-Finance from 2024.
Mr. House also formerly worked at Avid Bioservices, Inc., as Controller, Windes, Inc., as Senior Auditor, and ZO Skin Health, Inc., as Vice President-Accounting & Controller from 2018 to 2024.
Mr. House received his undergraduate degree from California State University-Fullerton.
Aktive Positionen von David House
| Unternehmen | Position | Beginn |
|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 16.08.2024 |
Ehemalige bekannte Positionen von David House
| Unternehmen | Position | Ende |
|---|---|---|
ZO Skin Health, Inc.
ZO Skin Health, Inc. Household/Personal CareConsumer Non-Durables Manufactures and retails skincare products through online | Comptroller/Controller/Auditor | 01.05.2024 |
| AVID BIOSERVICES, INC. | Comptroller/Controller/Auditor | - |
Windes, Inc.
Windes, Inc. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Comptroller/Controller/Auditor | - |
Ausbildung von David House
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Avid Bioservices, Inc.
Avid Bioservices, Inc. Pharmaceuticals: MajorHealth Technology Engages in the developing and manufacturing of biologics | Health Technology |
California State University-Fullerton
California State University-Fullerton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Windes, Inc.
Windes, Inc. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
ZO Skin Health, Inc.
ZO Skin Health, Inc. Household/Personal CareConsumer Non-Durables Manufactures and retails skincare products through online | Consumer Non-Durables |
Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on the development and commercialization of novel targeted antimicrobials | Health Technology |
















